Clinical predictors of pseudoprogression in glioblastoma: a retrospective cohort analysis.
Saved in:
| Title: | Clinical predictors of pseudoprogression in glioblastoma: a retrospective cohort analysis. |
|---|---|
| Authors: | Hoosemans LJN; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, Netherlands., Panayotopoulos LF; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, Netherlands. Lukas.panayotopoulos@mumc.nl., van Kuijk SMJ; Department of Clinical Epidemiology & Medical Technology Assessment, Maastricht University Medical Center+, Maastricht, The Netherlands., Verduin M; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, Netherlands., Anten MHME; Department of Neurology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands., Pasmans RCOS; Department of Neurology, Zuyderland Medical Center, Heerlen, The Netherlands., Schellekens JM; Department of Neurology, Zuyderland Medical Center, Heerlen, The Netherlands., Huijs SMH; Department of Neurology, Zuyderland Medical Center, Heerlen, The Netherlands., Verhoeff SR; Department of Medical Oncology, Zuyderland Medical Center, Sittard-Geleen, The Netherlands., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Center, Sittard-Geleen, The Netherlands., Steggink LC; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, Netherlands., Ackermans L; Department of Neurosurgery, Maastricht University Medical Center+, Maastricht, The Netherlands., Schijns OEMG; Department of Neurosurgery, Maastricht University Medical Center+, Maastricht, The Netherlands.; Academic Centre for Epileptology, Maastricht University Medical Center+ and Kempenhaeghe, Maastricht, Heeze, The Netherlands.; Mental Health and Sciences Research Institute (Mhens), Maastricht University, Maastricht, The Netherlands., Teernstra OPM; Department of Neurosurgery, Maastricht University Medical Center+, Maastricht, The Netherlands., Hovinga K; Department of Neurosurgery, Maastricht University Medical Center+, Maastricht, The Netherlands., Beckervordersandforth JC; Department of Pathology, Maastricht University Medical Center+, Maastricht, The Netherlands., Compter I; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, Netherlands., Eekers DBP; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, Netherlands., Postma AA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands.; Mental Health and Sciences Research Institute (Mhens), Maastricht University, Maastricht, The Netherlands., Vooijs MA; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, Netherlands., Broen MPG; Department of Neurology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands., Hoeben A; Department of Medical Oncology, GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, Netherlands. |
| Source: | Journal of neuro-oncology [J Neurooncol] 2025 Oct 24; Vol. 176 (1), pp. 42. Date of Electronic Publication: 2025 Oct 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
